← FDA Drug Approvals (Drugs@FDA)

TELMISARTAN AND AMLODIPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2016-11-17

Drug application

FDA Application #

ANDA205234

Application type

Abbreviated New Drug Application (Generic)

Brand name

TELMISARTAN AND AMLODIPINE

Generic name

TELMISARTAN AND AMLODIPINE

Active ingredients

AMLODIPINE BESYLATE; TELMISARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Limited

First approval

2016-11-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown